Herantis Pharma Oyj (HRTIS.HE)
EUR 1.66
(0.91%)
EUR 1.66
(0.91%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.02 EUR | 102.55% |
| 2022 | -0.64 EUR | 40.16% |
| 2021 | -2.20 EUR | 7.58% |
| 2020 | -1.18 EUR | 8.33% |
| 2019 | -1.30 EUR | -77.78% |
| 2018 | -0.85 EUR | -92.86% |
| 2017 | -0.51 EUR | 58.82% |
| 2016 | -1.02 EUR | 72.8% |
| 2015 | -3.75 EUR | -82.93% |
| 2014 | -3.05 EUR | -978.95% |
| 2013 | -0.67 EUR | -166.85% |
| 2012 | -71.16 EUR | 72.62% |
| 2011 | -261.53 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.07 EUR | -212.12% |
| 2024 Q2 | -0.07 EUR | 0.0% |
| 2023 FY | - EUR | 102.23% |
| 2023 Q3 | 0.06 EUR | 211.86% |
| 2023 Q4 | 0.06 EUR | 0.0% |
| 2023 Q2 | -0.05 EUR | 0.0% |
| 2023 Q1 | -0.05 EUR | 51.73% |
| 2022 Q2 | -0.47 EUR | -95.83% |
| 2022 Q1 | -0.24 EUR | 44.19% |
| 2022 FY | - EUR | 40.16% |
| 2022 Q4 | -0.22 EUR | -100.0% |
| 2022 Q3 | -0.11 EUR | 76.6% |
| 2021 Q4 | -0.43 EUR | -86.96% |
| 2021 Q1 | -0.41 EUR | 26.79% |
| 2021 FY | - EUR | 7.58% |
| 2021 Q3 | -0.23 EUR | 70.13% |
| 2021 Q2 | -0.77 EUR | -87.8% |
| 2020 Q2 | -0.62 EUR | -87.88% |
| 2020 Q4 | -0.56 EUR | -93.1% |
| 2020 FY | - EUR | 8.33% |
| 2020 Q1 | -0.33 EUR | 54.79% |
| 2020 Q3 | -0.29 EUR | 53.23% |
| 2019 Q2 | -0.57 EUR | -90.0% |
| 2019 Q3 | -0.38 EUR | 33.33% |
| 2019 FY | - EUR | -77.78% |
| 2019 Q1 | -0.30 EUR | -20.0% |
| 2019 Q4 | -0.73 EUR | -92.11% |
| 2018 Q3 | -0.25 EUR | -38.89% |
| 2018 Q4 | -0.25 EUR | 0.0% |
| 2018 FY | - EUR | -92.86% |
| 2018 Q2 | -0.18 EUR | 0.0% |
| 2018 Q1 | -0.18 EUR | -1039.24% |
| 2017 FY | - EUR | 58.82% |
| 2017 Q4 | -0.02 EUR | 0.0% |
| 2017 Q3 | -0.02 EUR | 93.68% |
| 2017 Q2 | -0.25 EUR | 0.0% |
| 2017 Q1 | -0.25 EUR | 44.44% |
| 2016 Q2 | -0.32 EUR | 0.0% |
| 2016 FY | - EUR | 72.8% |
| 2016 Q4 | -0.45 EUR | -104.55% |
| 2016 Q3 | -0.22 EUR | 31.25% |
| 2016 Q1 | -0.32 EUR | 47.54% |
| 2015 Q3 | -0.30 EUR | 82.04% |
| 2015 FY | - EUR | -22.95% |
| 2015 Q1 | -1.67 EUR | -131.94% |
| 2015 Q2 | -1.67 EUR | 0.0% |
| 2015 Q4 | -0.61 EUR | -103.33% |
| 2014 Q1 | -0.16 EUR | -403.14% |
| 2014 Q3 | -0.72 EUR | -10.77% |
| 2014 Q2 | -0.65 EUR | -306.25% |
| 2014 Q4 | -0.72 EUR | 0.0% |
| 2014 FY | - EUR | -376.56% |
| 2013 FY | - EUR | 99.1% |
| 2013 Q4 | -0.03 EUR | 0.0% |
| 2013 Q1 | -0.03 EUR | 0.0% |
| 2013 Q3 | -0.03 EUR | 59.85% |
| 2013 Q2 | -0.08 EUR | -126.93% |
| 2012 FY | - EUR | -5879.83% |
| 2011 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biohit Oyj | 0.12 EUR | 86.417% |
| Nanoform Finland Oyj | -0.26 EUR | 106.269% |